71 related articles for article (PubMed ID: 22210745)
1. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.
Dubey RK; Fingerle J; Gillespie DG; Mi Z; Rosselli M; Imthurn B; Jackson EK
Hypertension; 2015 Dec; 66(6):1207-19. PubMed ID: 26416848
[TBL] [Abstract][Full Text] [Related]
3. Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits.
Yang X; Gong Y; He Q; Licht JD; Liaw L; Friesel RE
J Cell Biochem; 2018 Apr; 119(4):3267-3279. PubMed ID: 29105817
[TBL] [Abstract][Full Text] [Related]
4. miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP.
Castagnino P; Kothapalli D; Hawthorne EA; Liu SL; Xu T; Rao S; Yung Y; Assoian RK
PLoS One; 2013; 8(2):e56140. PubMed ID: 23409140
[TBL] [Abstract][Full Text] [Related]
5. The amelioration of renal damage in Skp2-deficient mice canceled by p27 Kip1 deficiency in Skp2-/- p27-/- mice.
Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Liu N; Niida H; Nakayama K; Nakayama KI; Yamamoto T; Kitagawa M
PLoS One; 2012; 7(4):e36249. PubMed ID: 22558406
[TBL] [Abstract][Full Text] [Related]
6. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
[TBL] [Abstract][Full Text] [Related]
7. Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma.
Zhang W; Ren Z; Jia L; Li X; Jia X; Han Y
Biomed Res Int; 2019; 2019():9648269. PubMed ID: 31534970
[TBL] [Abstract][Full Text] [Related]
8. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH
Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717
[TBL] [Abstract][Full Text] [Related]
9. The SKP2-p27 axis defines susceptibility to cell death upon CHK1 inhibition.
Lohmüller M; Roeck BF; Szabo TG; Schapfl MA; Pegka F; Herzog S; Villunger A; Schuler F
Mol Oncol; 2022 Aug; 16(15):2771-2787. PubMed ID: 35673965
[TBL] [Abstract][Full Text] [Related]
10. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting.
Massfelder T; Dann P; Wu TL; Vasavada R; Helwig JJ; Stewart AF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13630-5. PubMed ID: 9391077
[TBL] [Abstract][Full Text] [Related]
11. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.
Timmerbeul I; Garrett-Engele CM; Kossatz U; Chen X; Firpo E; Grünwald V; Kamino K; Wilkens L; Lehmann U; Buer J; Geffers R; Kubicka S; Manns MP; Porter PL; Roberts JM; Malek NP
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14009-14. PubMed ID: 16966613
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of SCF
Wang J; Ferrena A; Zhang R; Singh S; Viscarret V; Al-Harden W; Aldahamsheh O; Borjihan H; Singla A; Yaguare S; Tingling J; Zi X; Lo Y; Gorlick R; Schwartz EL; Zhao H; Yang R; Geller DS; Zheng D; Hoang BH
Oncogene; 2024 Mar; 43(13):962-975. PubMed ID: 38355807
[TBL] [Abstract][Full Text] [Related]
13. N-Myc transcriptionally activates Skp2 to suppress p27 expression in small cell lung cancer.
Zou J; Lin Y; Hu M; Wan M; Tan X; Xu X; Xu F
Pathol Res Pract; 2022 Oct; 238():154083. PubMed ID: 36027654
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Cell Flow-Mediated Quiescence Is Temporally Regulated and Utilizes the Cell Cycle Inhibitor p27.
Tanke NT; Liu Z; Gore MT; Bougaran P; Linares MB; Marvin A; Sharma A; Oatley M; Yu T; Quigley K; Vest S; Cook JG; Bautch VL
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1265-1282. PubMed ID: 38602102
[TBL] [Abstract][Full Text] [Related]
15. Impaired germ cell development due to compromised cell cycle progression in Skp2-deficient mice.
Fotovati A; Nakayama K; Nakayama KI
Cell Div; 2006 Apr; 1():4. PubMed ID: 16759351
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Targeting p27
Trinh J; Shin J; Rai V; Agrawal DK
Arch Intern Med Res; 2024; 7(2):73-79. PubMed ID: 38737892
[TBL] [Abstract][Full Text] [Related]
17.
Chou PY; Lu YT; Sheu MJ
Food Sci Nutr; 2023 Dec; 11(12):7900-7909. PubMed ID: 38107129
[TBL] [Abstract][Full Text] [Related]
18. Myc degradation: dancing with ubiquitin ligases.
Amati B
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8843-4. PubMed ID: 15187232
[No Abstract] [Full Text] [Related]
19. L-Arginine Enhances Oral Keratinocyte Proliferation under High-Glucose Conditions via Upregulation of
Shi J; Leonardo TR; Han C; Bangash HI; Chen D; Trivedi HM; Chen L
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894498
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell flow-mediated quiescence is temporally regulated and utilizes the cell cycle inhibitor p27.
Tanke NT; Liu Z; Gore MT; Bougaran P; Linares MB; Marvin A; Sharma A; Oatley M; Yu T; Quigley K; Vest S; Cook JG; Bautch VL
bioRxiv; 2024 Jan; ():. PubMed ID: 37662222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
